
On Demand Replay: 27th Annual Hypertension, Diabetes & Dyslipidemia Conference
![]() Hurry! Offer expires September 15, 2023 at 11:59 pm ET!
|
|
Course Content
DAY 1 – On Demand Replay: WEDNESDAY, June 21, 2023 | |
M. Cornier, MD | Important Clinical Changes in the ADA 2023 Standards of Medical Care |
J. Green, MD | Evolving Strategies for Kidney Protection in Type 2 Diabetes |
M. Cornier, MD | Obesity: The Importance of Weight Management in Treating Type 2 Diabetes |
J. Green, MD | Making it All Happen: Translating Clinical Trials in Diabetes into Clinical Practice |
M. Cornier, MD & J. Green, MD | Questions for the Faculty |
M. Cornier, MD & J. Green, MD | Cases in Diabetes |
DAY 2 – On Demand Replay: THURSDAY, June 22, 2023 | |
J. Basile, MD | An Update on Resistant Hypertension |
K. Ferdinand, MD | Do Social Determinants of Health Contribute to Our Failure to Control BP? |
N. Fisher, MD | Redesigning Our Approach to Blood Pressure Control |
K. Ferdinand, MD | Controlling Blood Pressure in the Patient with HFpEF |
N. Fisher, MD | Update on Primary Aldosteronism: More Common Than Realized |
J. Basile, MD, K. Ferdinand, MD, & N. Fisher, MD | Questions for the Faculty |
S. Juraschek, MD & Faculty Panel | Hypertension Cases |
DAY 3 – On Demand Replay: FRIDAY, June 23, 2023 | |
J. Underberg, MD | Challenges in the Management of Dyslipidemia |
N. Desai, MD | Contemporary Management of LDL-Cholesterol |
J. Underberg, MD | Diagnosis, Screening, and Management of Familial Hypercholesterolemia and LP(a) |
N. Desai, MD | Moving Beyond LDL-C: Newer Strategies in Lipid Management |
J. Underberg, MD & N. Desai, MD | Questions for the Faculty |
J. Underberg, MD & N. Desai, MD | Lipid Cases |
Program Overview
This CME activity is comprised of recordings from the 27th Annual Hypertension, Diabetes & Dyslipidemia Conference that took place in Charleston, South Carolina on June 21-23, 2023. This CME has been endorsed by the American Society of Hypertension (ASH), and Southeast Lipid Association is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. The CME conference will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice. This conference will address these and other issues confronting the clinician who treats challenging patients with diabetes, hypertension, and dyslipidemia. The participant will learn the most current information on these issues and will be able to apply these important clinical principles back to their everyday practice to improve the care of their patients. The format of this course is streaming-only (video recordings are not downloadable).
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Formulate an efficient and effective assessment and monitoring plan of a patient’s condition as it relates to hypertension, diabetes, and dyslipidemia.
- Utilize current guidelines in the diagnosis and management of hypertension, diabetes, and dyslipidemia.
- Develop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes and/or dyslipidemia that will lead to the reduction of modifiable risk factors and improved long term outcomes.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
Jan N. Basile, MD, FACP, FASH, FAHA (Conference Chairperson)
Professor of Medicine
Division of Cardiology
Medical University of South Carolina
Ralph H Johnson VA Medical Center
Previous Vice-Chair of Clinical Programs AHA Council of Hypertension
US National Leader SURPASS-CVOT
Charleston, SC
Marc-Andre Cornier, MD
Professor of Medicine with Tenure
James A. Keating Endowed Chair in Diabetes
Director, Division of Endocrinology, Diabetes & Metabolic Diseases
Medical University of South Carolina
Charleston, SC
Nihar R. Desai, MD, MPH
Associate Professor of Medicine, Yale School of Medicine
Associate Chief, Section of Cardiovascular Medicine
Investigator, Center for Outcomes Research and Investigation
New Haven, CT
Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA
Gerald S. Endowed Chair in Preventive Cardiology
Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA
Naomi DL Fisher MD
Associate Professor of Medicine, Harvard Medical School
Director of Hypertension Service and Hypertension Innovation
Division of Endocrinology, Diabetes and Hypertension
Brigham and Women’s Hospital
Boston, MA
Jennifer Green, MD
Professor of Medicine
Division of Endocrinology, Metabolism, and Nutrition
Duke University Medical Center
Durham VA Medical Center
Durham, NC
Stephen P. Juraschek, MD, PhD, FAHA, AHSCP-CHS
Assistant Professor, Harvard Medical School
Research Director, Hypertension Center at Healthcare Associates
Division of General Medicine, Section for Research, Beth Israel Deaconess Medical Center
Boston, MA
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
Lipidology & Cardiovascular Disease Prevention
Diplomate American Board of Clinical Lipidology
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President National Lipid Association
President American Board of Clinical Lipidology
New York, NY
Accreditation
American Academy of Family Physicians: The AAFP has reviewed the On Demand Replay: 27th Annual Hypertension, Diabetes and Dyslipidemia Conference (Enduring) and deemed it acceptable for up to 15.25 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 7/3/2023 to 6/1/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15.25 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15.25 hours of participation, 11 of which can be used towards Pharmacology, for completing this activity.
Release Date: 7/3/2023
Expiration Date: 6/1/2024 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that they have no relevant financial relationships with a ineligible company that may impact upon this CME activity:
- Jan Basile, MD – Chair/Moderator, see disclosures below
- Raymond E. Major, MD – Reviewer
- Walter Ejnes, CHCP – Reviewer & Planning Committee (Continuing Education Company)
- Lizzie Masters – Reviewer (Continuing Education Company)
- Beth Ryan Townsend, CHCP – Reviewer (Continuing Education Company)
- Su Barnwell – Planner (Continuing Education Company)
Faculty Disclosures:
The following individuals were responsible for developing their own content, which has been reviewed by Continuing Education Company’s Medical Education Advisory Committee to ensure it is unbiased. Additionally, all individuals have indicated that if they had a financial relationship(s) with an ineligible company over the past 24 months, this relationship has been mitigated and does not have an impact upon this CME activity. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Faculty | Disclosures |
Jan Basile, MD | Consultant: Eli Lilly (SURPASS-CVOT); UpToDate (Hypertension Section) |
Research Grant: Ablative Solutions (Target BP 1); ReCor (RADIANCE I and II) | |
Marc-Andre Cornier, MD | Advisory Board: Alnylam Pharmaceuticals; Letsgetchecked |
Consultant: Kaneka; Novo Nordisk | |
Research Grant: Amgen; Kaneka; Novartis | |
Nihar Desai, MD | Advisory Board: Novartis |
Consultant: Amgen; Astra Zeneca; Bayer; Boehringer Ingelheim; Cytokinetics; Novartis | |
Grant Recipient: Amgen; Astra Zeneca; Boehringer Ingelheim; Cytokinetics; Novartis; Vifor Pharma | |
Keith Ferdinand, MD | Consultant: Amgen; Eli Lilly; Sanofi |
Naomi Fisher, MD | Advisory Board: Recor Medical |
Consultant: Aktiia; Medtronic | |
Research Grant: Recor Medical | |
Jennifer Green, MD | Consultant: Anji; Astra Zeneca; Bayer; Boehringer Ingelheim/Lilly Alliance; Merck; Novo Nordisk; Pfizer; Sanofi; Valo; Vertex |
Research Grant: Boehringer Ingelheim/Lilly Alliance; Merck; Roche | |
Stephen Juraschek, MD | Nothing to Disclose |
James Underberg, MD | Advisory Board: Amgen; Esperion |
Consultant: Amgen | |
Research Grant: Amryt | |
Speaker’s Bureau: Amarin; Ambry; Amgen; GBinsight; Regeneron |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later

30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.